Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma
…, D Pellegrino, E Borsò, M Rondini… - Journal of Nuclear …, 2008 - Soc Nuclear Med
The aim of this study was to optimize a protocol for radioguided biopsy of the sentinel lymph
node (SLN) in patients with melanoma. The protocol was based on a combination of ex vivo …
node (SLN) in patients with melanoma. The protocol was based on a combination of ex vivo …
Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer
…, V Guarneri, E Landucci, C Orlandini, M Rondini… - Clinical Breast …, 2002 - Elsevier
The purpose of our study was to evaluate the feasibility and efficacy of weekly docetaxel/paclitaxel
in pretreated advanced breast cancer patients. Twenty-six patients with metastatic …
in pretreated advanced breast cancer patients. Twenty-six patients with metastatic …
Fulvestrant treatment is associated with cholesterol plasma level reduction in hormone receptor-positive metastatic breast cancer patients
A Camerini, M Rondini, O Garrone… - Cancer Biology & …, 2009 - Taylor & Francis
Background: Fulvestrant is a pure anti-estrogen hormonal agent formally lacking any
estrogen-agonist activity. We analyze the effect(s) of fulvestrant treatment on estrogen target …
estrogen-agonist activity. We analyze the effect(s) of fulvestrant treatment on estrogen target …
[HTML][HTML] Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: a case report
…, O Siclari, A Camerini, ML Canale, M Rondini… - Cases Journal, 2009 - Springer
Introduction sorafenib, a tyrosine-kinase inhibitor, is widely used in the treatment of advanced
hepatocellular carcinoma. Drug-related toxicities are generally mild but sorafenib, as other …
hepatocellular carcinoma. Drug-related toxicities are generally mild but sorafenib, as other …
Femoral Artery Leiomyosarcoma: Case Report and Literature Review
G Baldino, A Amico, M Rondini - Annals of Vascular Surgery, 2022 - Elsevier
Background Vascular leiomyosarcoma is a rare type of malignant tumor which arises from
the smooth muscle tissue of blood vessel walls; it involves veins five times more frequently …
the smooth muscle tissue of blood vessel walls; it involves veins five times more frequently …
[CITATION][C] FULVESTRANT TREATMENT IS ASSOCIATED WITH SERUM VEGF LEVELS REDUCTION IN HORMONE-SENSITIVE ADVANCED BREAST CANCER …
A Camerini, O Garrone, M Rondini, C Valsuani… - Annals of …, 2009 - hero.epa.gov
FULVESTRANT TREATMENT IS ASSOCIATED WITH SERUM VEGF LEVELS REDUCTION IN
HORMONE-SENSITIVE ADVANCED BREAST CANCER PATIENTS | Health & Environmental …
HORMONE-SENSITIVE ADVANCED BREAST CANCER PATIENTS | Health & Environmental …
[CITATION][C] Effect of fulvestrant treatment on complete blood lipid profile in hormone-sensitive metastatic breast cancer patients
…, O Siclari, C Puccetti, RP Porta, M Rondini… - Annals of …, 2007 - hero.epa.gov
Effect of fulvestrant treatment on complete blood lipid profile in hormone-sensitive metastatic
breast cancer patients | Health & Environmental Research Online (HERO) | US EPA Jump to …
breast cancer patients | Health & Environmental Research Online (HERO) | US EPA Jump to …
[CITATION][C] Combination of trastuzumab, oxaliplatin and docetaxel as first line treatment in HER2-positive advanced breast cancer patients: preliminary results of a …
D Amoroso, S Donati, M Rondini, C Valsuani… - … 11th National Congress …, 2009 - arpi.unipi.it
Combination of trastuzumab, oxaliplatin and docetaxel as first line treatment in HER2-positive
advanced breast cancer patients: preliminary results of a phase II trial (HOT Trial) IRIS IRIS …
advanced breast cancer patients: preliminary results of a phase II trial (HOT Trial) IRIS IRIS …
[CITATION][C] Session H: CNS Tumours, Neuroendocrine Tumours, Sarcoma and Melanoma
R Murr, S Sarti, M Rondini, G Manca, D Pellegrino…
[CITATION][C] BREAST CANCER, ADVANCED
…, S Donati, B Salvadori, E Baldini, M Rondini…